Cell therapy is a new trend in oncology where living cells are employed to identify and destroy cancer, providing customized and potent treatment. The session "Cell Therapy" is dedicated to the mechanisms, applications, and clinical progress in employing cellular therapies for treating cancer.".
Therapies like CAR T-cell therapy, tumor-infiltrating lymphocytes (TILs), and natural killer (NK) cell therapy utilize the patient's immune system or manipulated cells to identify and target tumor cells. Such treatments have a significant advantage in hematologic malignancies and are being researched increasingly for solid tumors. Since cell therapies target cancer cells directly, they can achieve durable responses as well as resist the kind of resistance elicited by traditional therapies.
The session also discusses challenges such as immune toxicities, manufacturing issues, and tumor microenvironment challenges. Progresses in gene editing, cell engineering, and biomarker-directed patient selection are improving safety, efficacy, and access. Combination approaches with other treatments are also being studied to maximize outcomes.
Delegates will learn about the biology, clinic practice, and new research developments in cell therapy. Highlighting the revolutionary value of using living cells to combat cancer, this session presents personalized, efficient, and cutting-edge treatment options that are redefining the future of cancer medicine.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
